SCHEMBL29488469

SCHEMBL29488469

O=C(CCCC/C=C(\COc1cccc2ccccc12)C(=O)NC1CCN(C2CCCC2)CC1)NO

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HDAC1 Q13547 6/20 0.41
▸ HDAC6 Q9UBN7 6/20 0.41
▸ HDAC3 O15379 3/20 0.41
▸ HDAC2 Q92769 3/20 0.41
▸ ALDH1A1 P00352 3/20 0.40
▸ PREP P48147 2/20 0.40
▸ P2RX3 P56373 1/20 0.39
▸ ADAMTS4 O75173 1/20 0.38
▸ ADAMTS5 Q9UNA0 1/20 0.38
▸ KDM4E B2RXH2 2/20 0.38
▸ SIGMAR1 Q99720 3/20 0.38
▸ HDAC4 P56524 2/20 0.37
▸ HDAC7 Q8WUI4 2/20 0.37
▸ HDAC10 Q969S8 2/20 0.37
▸ HDAC11 Q96DB2 2/20 0.37
▸ HDAC8 Q9BY41 2/20 0.37
▸ HDAC9 Q9UKV0 2/20 0.37
▸ HDAC5 Q9UQL6 2/20 0.37
▸ MEN1 O00255 1/20 0.37
▸ KMT2A Q03164 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1306742 1.00 HDAC1 (0.41) HDAC1HDAC6HDAC3HDAC2ALDH1A1
SCHEMBL1306745 1.00 HDAC1 (0.41) HDAC1HDAC6HDAC3HDAC2ALDH1A1
SCHEMBL29488479 0.97 P2RX3 (0.39) HDAC1HDAC6HDAC3HDAC2ALDH1A1
SCHEMBL1306050 0.97 P2RX3 (0.39) HDAC1HDAC6HDAC3HDAC2ALDH1A1
SCHEMBL1306054 0.97 P2RX3 (0.39) HDAC1HDAC6HDAC3HDAC2ALDH1A1
SCHEMBL29488483 0.93 P2RX3 (0.40) HDAC1HDAC6HDAC3HDAC2ALDH1A1
SCHEMBL1306269 0.93 P2RX3 (0.40) HDAC1HDAC6HDAC3HDAC2ALDH1A1
SCHEMBL1306273 0.93 P2RX3 (0.40) HDAC1HDAC6HDAC3HDAC2ALDH1A1
SCHEMBL1306825 0.92 ALDH1A1 (0.43) ALDH1A1PREPP2RX3ADAMTS4ADAMTS5
SCHEMBL1306829 0.92 ALDH1A1 (0.43) ALDH1A1PREPP2RX3ADAMTS4ADAMTS5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114340672-A Pharmaceutical composition comprising an HDAC inhibitor and an anti-PD 1 antibody or an anti-PD-L1 antibody 晶体基因技术株式会社 2022-04-12 — — CN claimed
CN-112930177-B Pharmaceutical compositions containing alkylcarbamoyl naphthoyl octenoyl hydroxyamide phosphate, tartrate or combinations thereof and methods of making the same 晶体基因技术株式会社 2024-01-30 — — CN disclosed
EP-4155292-A1 METHOD FOR PRODUCING PHARMACEUTICALLY ACCEPTABLE SALT OF ALKYLCARBAMOYL NAPHTHALENYLOXY OCTENOYLHYDROXYAMIDE Crystalgenomics, Inc. (KR) 2023-03-29 — — EP disclosed
CN-114340672-A Pharmaceutical composition comprising an HDAC inhibitor and an anti-PD 1 antibody or an anti-PD-L1 antibody 晶体基因技术株式会社 2022-04-12 — — CN disclosed
CN-110740989-B Pharmaceutically acceptable salts of alkylcarbamoylnaphthoxyoctenoylhydroxyamides or derivatives thereof and process for preparing the same 晶体基因技术株式会社 2022-03-08 — — CN disclosed
Send feedback